Figure 1.
Figure 1. High number of circulating CD56bright NK cells correlated with better overall survival, and less TRM. Patients were subgrouped into ‘High’, ‘Middle’, and ‘Low’, group based on 33% and 67% percentage of circulating CD56bright NK cell count by day 14 after transplantation. Kaplan-Meier survival estimates OS (Figure 1A) in these three groups and cumulative incidence estimates TRM (Figure 1B).

High number of circulating CD56bright NK cells correlated with better overall survival, and less TRM. Patients were subgrouped into ‘High’, ‘Middle’, and ‘Low’, group based on 33% and 67% percentage of circulating CD56bright NK cell count by day 14 after transplantation. Kaplan-Meier survival estimates OS (Figure 1A) in these three groups and cumulative incidence estimates TRM (Figure 1B).

This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal